Skip to main content

Table 4 Demographics

From: First-in-human study of TK-positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells

Age (years)

 Median

60.4

 Range

19–92

Gender

N

%

 Male

15

58

 Female

11

42

Cancer type

N

%

 Lung cancer

1

4

 Breast cancer

2

8

 Prostate cancer

3

12

 AML

2

8

 Pancreatic cancer

2

8

 Colorectal cancer

2

8

 Head and Neck cancer

4

15

 Adrenal cancer

1

4

 Liver cancer

1

4

 Astrocytoma

1

4

 Bronchial carcinoid

1

4

 Ovarian cancer

1

4

 Uterine cancer

1

4

 Sarcomatoid

1

4

 Squamous cell carcinoma neck

1

4

 Esophageal cancer

1

4

 Thyroid cancer

1

4

Route of administration

N

%

 Intravenous (IV)

6

23

 Intravenous + Intratumoral

15

58

 Intratumoral (IT)

1

4

 Intraperitoneal (IP) +IV

3

12

 IV + IT + IP

1

4